
Causaly is the leading AI platform for life sciences, combining advanced AI, a high-precision knowledge graph, and seamless adoption to enhance R&D productivity and mitigate risks. Their platform empowers R&D teams to find, interpret, and share biomedical information efficiently. Key products include Generative AI Copilot for asking complex biomedical questions, a Knowledge Graph for precise data analysis, an Enterprise Data Fabric for integrating internal and external data, and Scientific RAG for information retrieval. Causaly aims to accelerate drug discovery and development by providing scientists with a "single source of truth" and robust AI tools. The company was co-founded in 2018 by computer scientists Yiannis Kiachopoulos and Artur Saudabayev, with headquarters in London and offices in New York and Greece.

Causaly is the leading AI platform for life sciences, combining advanced AI, a high-precision knowledge graph, and seamless adoption to enhance R&D productivity and mitigate risks. Their platform empowers R&D teams to find, interpret, and share biomedical information efficiently. Key products include Generative AI Copilot for asking complex biomedical questions, a Knowledge Graph for precise data analysis, an Enterprise Data Fabric for integrating internal and external data, and Scientific RAG for information retrieval. Causaly aims to accelerate drug discovery and development by providing scientists with a "single source of truth" and robust AI tools. The company was co-founded in 2018 by computer scientists Yiannis Kiachopoulos and Artur Saudabayev, with headquarters in London and offices in New York and Greece.
What they do: Enterprise AI platform and high-precision biomedical knowledge graph to accelerate drug discovery and R&D
Founded: 2018
Headquarters / offices: London; offices in New York and Greece
Recent funding: Series B $60M (Jul 13, 2023); $93M total raised
Founders / leadership: Yiannis Kiachopoulos (CEO), Artur Saudabayev (CTO)
Biomedical research and drug discovery R&D productivity and risk mitigation
2018
Software Development
60000000
Raised $60M; brought total funding to $93M
17000000
4800000
“Includes strategic and growth investors such as ICONIQ Growth, Index Ventures, Marathon Venture Capital, EBRD Venture Capital, Pentech Ventures and individual strategic backers”
| Company |
|---|
Founded in 2018, Causaly’s AI platform for enterprise-scale scientific research redefines the limits of human productivity. We provide a powerful new way to find, visualize, and interpret biomedical knowledge, automating critical research workflows to accelerate solutions for significant health challenges.
We collaborate with some of the world's largest biopharma companies and institutions on use cases spanning:
Causaly is backed by top VCs including ICONIQ, Index Ventures, Pentech, and Marathon.
Job Title: Engineering Manager
Location: London
Employment Type: Full-time
Location Type: Hybrid
Department: Technology
We are hiring an engineering manager to help expand our platform for consuming and making sense of private data. Pharmaceutical institutions have accumulated thousands of person-years of scientific expertise and wisdom; we utilize AI models to help scientists find novel connections and insights from this proprietary data.